Innovative Technology
- Energy ModalityLow-Level Light Therapy (LLLT) with Optical Lens Array
- Optical Parameters830 nm (with 590 nm yellow pre-treatment)
- Core CharacteristicFDA-cleared 830nm near-infrared Low-Level Light Therapy
2. Energy-Based Devices · CYNOSURE LUTRONIC

Clinical Philosophy
An FDA-cleared Low-Level Light Therapy (LLLT) device that uses 830nm near-infrared light to deeply target dermal skin cells. This approach heightens the cells’ action potential and fosters photostimulation of dermal microcirculation. The end result is relief from minor muscle and joint pain, stiffness, arthritis, and muscle spasms.
Mechanism of Action: HEALITE II delivers concentrated 830nm near-infrared light (with optional 590nm pre-illumination) that penetrates deep into dermal tissues. Photons are absorbed by cellular cytochrome c oxidase, boosting ATP production, enhancing cellular repair mechanisms, and stimulating microcirculation without heat or tissue ablation.
Distributed exclusively across Cambodia through NOVIRA. We empower dermatologists, aesthetic practitioners, and licensed clinics with authentic technology, protocol masterclasses, and dependable after-sales clinical support.
Special Features
Rigorous scientific evidence, targeted clinical efficacy, and certified safety.
SAY GOODBYE
Documented clinical transformations achieved with our medical aesthetic platforms and biostimulator formulations. Drag the slider to reveal clinical outcomes.
CYNOSURE LUTRONIC Portfolio
Distributed exclusively to authorized aesthetic clinics and licensed practitioners.

Synchronized neuromuscular, electromagnetic, and radiofrequency body remodeling

Independent multi-mode energy control for precise facial lifting and skin quality

Ultrasound energy for minimally invasive aesthetic body contouring
Clinical Spotlight


Speak with our clinical partnership team about equipment demonstration, physician masterclasses, and authorized supply for CYNOSURE LUTRONIC.